Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Orphazyme A/S - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.15

up-down-arrow $-0.19 (-55.61%)

As on 26-May-2022 09:30EDT

Market cap

info icon

$37 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 0.00 -69.37 -217.19 -238.26 -263.50
Net Profit -- -- -87.63 -244.51 -262.33
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-20Dec-19
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info -128.92-151.50---188.05-152.98
Return on Capital info -110.06-206.36---154.20-130.23
Return on Assets info -92.11-82.36-26.34-126.24-108.50
Debt to Equity (x) info ----0.080.111.46

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
--
-154.20
-130.23
-45.74
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
--
-188.05
-152.98
-45.74
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

--

--

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
-26.34
-126.24
-108.50
-41.59
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
-217.19
-81.30
-44.93
-76.72
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
-51.87
-87.63
-46.99
-81.93
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
0.08
0.11
1.46
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
0.22
0.06
0.30
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

--

--

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
1.80
4.70
2.25
7.99
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
1.80
--
--
--
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
-16.98
--
--
--
Peer Median
-0.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Orphazyme A/S - ADR
--
--
--
--
--
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...